Abstract

Primary nephrotic syndrome (PNS) is a devastating pediatric disorder. However, its mechanism remains unclear. Previous studies detected B7-1 in podocytes; meanwhile, γδT cells play pivotal roles in immune diseases. Therefore, this study aimed to assess whether and how γδT cells impact podocytes via the CD28/B7-1 pathway. WT and TCRδ−/− mice were assessed. LPS was used to induce nephropathy. Total γδT and CD28+γδT cells were quantitated in mouse spleen and kidney samples. B7-1 and phosphor-SRC levels in the kidney were detected as well. In vitro, γδT cells from the mouse spleen were cocultured with mouse podocytes, and apoptosis rate and phosphor-SRC expression in podocytes were assessed. Compared with control mice, WT mice with LPS nephropathy showed increased amounts of γδT cells in the kidney. Kidney injury was alleviated in TCRδ−/− mice. Meanwhile, B7-1 and phosphor-SRC levels were increased in the kidney from WT mice with LPS nephropathy. CD28+γδT cells were decreased, indicating CD28 may play a role in LPS nephropathy. Immunofluorescence colocalization analysis revealed a tight association of γδT cells with B7-1 in the kidney. High B7-1 expression was detected in podocytes treated with LPS. Podocytes cocultured with γδT cells showed higher phosphor-SRC and apoptosis rate than other cell groups. Furthermore, CD28/B7-1 blockage with CTLA4-Ig in vitro relieved podocyte injury. γδT cells exacerbate podocyte injury via CD28/B7-1 signaling, with downstream involvement of phosphor-SRC. The CD28/B7-1 blocker CTLA4-Ig prevented progressive podocyte injury, providing a potential therapeutic tool for PNS.

Highlights

  • Primary nephrotic syndrome (PNS), characterized by proteinuria, hypoalbuminemia, hyperlipidemia, and edema, has become a devastating disorder in children

  • PNS can be divided into minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), mesangial proliferative glomerulonephritis (MPGN), and membranous nephropathy (MGN)

  • The findings indicated that LPS nephropathy simulates MCD

Read more

Summary

Introduction

Primary nephrotic syndrome (PNS), characterized by proteinuria, hypoalbuminemia, hyperlipidemia, and edema, has become a devastating disorder in children. PNS can be divided into minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), mesangial proliferative glomerulonephritis (MPGN), and membranous nephropathy (MGN). MCD accounts for nearly 80% of pediatric cases. Most children with MCD respond well to corticosteroid treatment, but relapse and corticosteroid resistance still constitute important clinical challenges. In 1974, Shalhoub proposed that T cell dysfunction could be the mechanism underlying nephrosis [1]. Subsets of altered CD4+T cells have been reported in PNS patients. We found Th17/Treg subset dysfunction in pediatric PNS [2]. This phenomenon cannot totally explain the mechanism of PNS, especially in its early phase.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call